Introduction
Although it is a rare disorder, scleromyxedema (lichen myxedematosus) is one of the most common forms of primary cutaneous mucinosis. This condition is a generalized form of dermal mucin deposition characterized by waxy papules that progresses to indurated and thickened skin and is often associated with monoclonal gammopathy, particularly of the immunoglobulin G type. 1 Lichen myxedematosus has been rarely reported to be associated with internal malignancies 2 ( Table 1) . To our knowledge, the coexistence of thymic carcinoma and lichen myxedematosus in the same patient has never previously been documented. In this article, we describe, for the first time of our knowledge, a case of scleromyxedema associated with thymic carcinoma.
Case Report
A 66-year-old man underwent palliative chemotherapy for an inoperable thymic carcinoma from 2008 to 2009. A computed tomographic scan of the chest in May 2008 showed a large, left-anterior mediastinal mass (7.4 ϫ 6.3 ϫ 6.8 cm) attached to the pleural surface. Video-assisted thoracoscopy revealed pleural metastases, which indicated Masaoka stage IVa disease. Histologic examination of the pleural specimen confirmed the diagnosis of thymic carcinoma. Surgical intervention was not considered in view of the advanced disease status. Nine courses of chemotherapy with carboplatin and paclitaxel were completed by May 2009. Serial imagings showed a 50% shrinkage of the tumor size and absence of distant metastasis. The patient remained asymptomatic after chemotherapy.
Two years after the diagnosis of thymic carcinoma, the patient was admitted for an extensive rash in April 2010. The rash initially involved the wrists and hands and later spread to involve the proximal arms, trunk, buttock, and face. Progressive skin thickening was noted over the affected areas, which led to mild impairment in the movement of wrists and fingers. On examination, there were numerous erythematous to violaceous firm, waxy papules over the face, neck, upper limbs, trunk, and thighs. Crops of papules coalescented to form indurated plaques over the forearms, hands, upper chest, and back (Figs 1 and 2). Deep longitudinal furrowing of the skin of the glabella and nodules on the face gave a leonine appearance (Fig 3) .
A biopsy from indurated skin on the back showed a busy dermis with stellate fibroblasts between disorganized collagen bundles with a whorled appearance within the reticular dermis (Fig 4) . Occasional mast cells and eosinophils were present, and lymphocytes were noted around some of the small vessels. Delicate strands of hyaluronic acid mucin for alcian blue at pH 2.5 separated collagen fibers within dermis JOURNAL OF CLINICAL ONCOLOGY (Fig 5) . The histopathology and clinical appearance were typical of scleromyxedema. No monoclonal gammopathy was detected. The patient was received potent topical corticosteroid (beclomethasone dipropionate 0.1%) for symptomatic treatment.
In the next 2 months, there was a partial regression of the skin thickening and resolution of some of the facial nodules. The patient was being followed up regularly for screening of systemic complications and paraproteinaemia associated with scleromyxedema. He developed pericardial effusion in October 2010, 6 months after onset of the skin lesions, and a pericardial window was created. Disease progression was evidenced by an interval increase in size of the anterior mediastinal tumor and pleural extension at the left hemithorax with encasement of the left lung in a subsequent computed tomographic scan of the chest. The patient preferred conservative management and opted not to have additional palliative chemotherapy. There was progressive dyspnea, for which the patient required home oxygen therapy, and the patient became home bound. He was referred to the palliative care unit for symptomatic treatment.
Discussion
Scleromyxedema is a generalized form of lichen myxedematosus characterized by a widespread symmetrical eruption of small, waxy, and closely spaced papules distributed over the arms, face, neck, upper trunk, and thighs. Affected skin may exhibit diffuse erythema, edema, and a shiny appearance. Typical leonine facies may be observed in patients with excessive mucin deposition in the skin of the glabella. The histopathology includes the classic triad of dermal mucin deposition, proliferation of fibroblast, and disorganized collagen production. Systemic complications are often disabling and due to visceral deposition of mucin. These complications include esophageal aperistalsis, myopathy, obstructive or restrictive lung diseases, peripheral neuropathy, and carpal tunnel syndrome. Scleromyxedema is potentially lethal in the setting of internal organ involvement and carries a significant mortality. 1 Thymomas may be associated with a variety of paraneoplastic disorders, including myasthenia gravis, pure red cell aplasia, and hypogammaglobulinaemia. Several cutaneous manifestations were reported to be associated with thymoma ( Table 2 ). The manifestations were postulated to be related to a graft-versus-host-like reaction. 13 The pathogenesis of lichen myxedematosus is unknown. The presence of serum paraprotein does not correlate with the extent or progress of the disease. Although serum from patients with scleromyxedema enhanced fibroblast proliferation in vitro, an immunoglobulin purified from the paraprotein-containing serum failed to do so. 15, 16 It is likely that a nonparaprotein serum fibroblast growth factor or immune dysregulation is involved in the development of lichen myxedematosus. The thymus is an important organ of the immune system of the body, and one of main functions of the thymus is to ensure self-tolerance. Immature thymocytes undergo maturation and negative selection in the thymus, by which T cells that possess receptors specific for self-cell-surface proteins are eliminated. In thymic neoplasms, T cells are thought to mature in an abnormal environment, and some self-reactive T cells may fail to be deleted. This effect may help to explain the various paraneoplastic phenomena associated with thymomas. We believe that the development of scleromyxedema in our patient could be related to the immune dysregulation in the setting of underlying thymic neoplasia and might signify progression of the tumor. It would seem prudent for clinicians to consider investigations for internal malignancies when lichen myxedematosus is diagnosed because this could lead to earlier detection and better prognosis of the patient as well as shedding further light on the pathoetiology of this unusual skin condition. Furthermore, oncologists, cardiothoracic surgeons, and physicians should be aware of such an otherwise uncommon skin manifestation in patients with thymic neoplasms. Referrals to dermatologists and screening for systemic complications may help in the reduction of morbidities and, perhaps, mortality of this potentially disabling condition. 
